Delivery Order SPE2DB22D3011-SPE2DB24FQ1LP
Award Date 5/22/24
Potential Completion Date 5/23/24
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC enables Amerisourcebergen to efficiently supply a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Myrbetriq Extended Release 25 mg tablets to the government. The contract, valued at $46,586.96, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The delivery order is a firm fixed-price contract with a completion date of May 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA). The $43,717.10 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 27, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA), a Defense agency. The contract, valued at $11,914.30, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2024 with a completion date of September 25, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing structure, with no set-aside designation. Amerisourcebergen is the prime contractor, and the contract is associated...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,840.66 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024, with an ultimate completion date of November 27, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets, valued at $50,443.65. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a Firm Fixed Price Delivery Order that will be completed by November 1, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of the drug Myrbetriq ER 25 mg tablets. The contract is a Delivery Order with a Firm Fixed Price, valued at $5,891.74, and has an ultimate completion date of April 22, 2024. Amerisourcebergen, through its Corporate Office Division, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. The contract, valued at $33,163.11, is a firm-fixed price delivery order with a period of performance through January 11, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the U.S. Department of Defense (DoD) and its Medical Supply Chain agency. The $3,467.98 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. The contract has a ceiling value of $7,601.93 and is a firm fixed-price delivery order. It was awarded on January 26, 2022, with a completion date of January 27, 2022. The contract does not have a set-aside...